Position in LH
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$5,527,200
+$2,456,218 QoQ
Shares Held
19,740
+71.5% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#232
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026OPPENHEIMER ASSET MANAGEMENT INC. holds $122,739,286 across 17 Diagnostics & Research names. LH ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
180,977 | $34,472,495 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
50,195 | $25,165,762 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
27,079 | $14,340,763 | |
| 4 | A |
Agilent Technologies, Inc.
|
96,824 | $12,861,131 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
23,535 | $12,389,762 | |
| 6 | LH |
Labcorp Holdings Inc.
This page
|
19,740 | $5,527,200 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
22,035 | $4,997,316 | |
| 8 | NTRA |
Natera, Inc.
|
14,142 | $3,838,845 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,527,200 | 19,740 | Shares | Other | 2026-08-03 | |
| 2026-03-31 | $3,070,982 | 11,510 | Shares | Other | 2026-04-24 | |
| 2025-12-31 | $2,632,733 | 10,494 | Shares | Other | 2026-02-02 | |
| 2025-09-30 | $2,934,900 | 10,224 | Shares | Other | 2025-11-06 | |
| 2025-06-30 | $3,269,298 | 12,454 | Shares | Other | 2025-07-31 | |
| 2025-03-31 | $2,922,281 | 12,556 | Shares | Other | 2025-04-23 | |
| 2024-12-31 | $2,930,707 | 12,780 | Shares | Other | 2025-02-05 | |
| 2024-09-30 | $2,846,016 | 12,735 | Shares | Other | 2024-11-05 | |
| 2024-06-30 | $2,496,048 | 12,265 | Shares | Other | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||